Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer
Authors:
- 21 October 2015
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (3) , 4135-4142
Abstract
Inflammation and tumor immune microenviroment are critical factors for prognosis in numerous cancers. The aim of this study was to determine the prognostic value of preoperative neutrophil-to-lymphocyte ratio (NLR) in breast cancer. We performed a retrospective analysis of 487 patients diagnosed with primary breast cancer at Shanghai Ruijin hospital from January 2009 to December 2010. Hematological parameters before surgery, clinicopathological data, and survival status were obtained. Survival analysis was used to evaluate the prognostic value of NLR. The optimal cutoff value was determined as 1.93 for NLR and the median follow-up time was 55.0 months. On univariate analysis, patients with high NLR (>1.93) had worse 5-year disease-free survival (DFS) compared to those with low NLR (77.9 vs 88.0 %, p = 0.002). Regarding overall survival, there was no significant difference between patients with high NLR and low NLR, with 5-year overall survival of 90.8 and 91.7 % (p = 0.707). In triple-negative breast cancer, patients with high NLR was associated with worse 5-year DFS compared with patients with low NLR (63.4 vs 84.9 %, p = 0.040). Mutivariate analysis revealed that NLR was an independent prognostic factor for DFS in breast cancer (HR = 1.867, 95 % confidence interval; (95%CI) = 1.155–3.017, p = 0.011). Preoperative NLR is an independent predictor of DFS in breast cancer patients, especially in triple-negative subtype. Further studies are required to validate the prognostic value of NLR before clinical application.Keywords
Funding Information
- Technology Innovation Act Plan of Shanghai Municipal Science and Technology Commission (14411950200, 14411950201)
This publication has 42 references indexed in Scilit:
- Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate CancerJNCI: Journal of the National Cancer Institute, 2014
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Breast cancer in ChinaThe Lancet Oncology, 2014
- Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer PatientsJournal of Breast Cancer, 2013
- Gene expression profiling in breast cancer: classification, prognostication, and predictionThe Lancet, 2011
- Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast CancerJournal of Clinical Oncology, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Breast Cancer Cells Stimulate Neutrophils to Produce Oncostatin M: Potential Implications for Tumor ProgressionCancer Research, 2005
- Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic modelBritish Journal of Cancer, 2005
- Cyclin E and Survival in Patients with Breast CancerNew England Journal of Medicine, 2002